Moreover, increased S100A9 expression is associated with poor tumor differentiation [24], poor pathological parameters [26], high tumor grade [27], increased tumor recurrence and metastasis [28, 29], and a poor prognosis of patients with breast cancer [25, 30, 31]. The gene discussed is S100A9; the disease is breast carcinoma.